Responses
Reviews
Tardive movement disorders: a practical approach
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 4 January 2012
- Published on: 4 January 2012Amantadine for Tardive dyskinesia: active in patients with overactive NMDA receptorsShow More
In the Saifee TA et al article (1) regarding the treatment of "Tardive movment disorders" (TD), the authors recommend the use of amantadine as second or third line among other possible drugs ("each with fairly limited evidence for effectiveness" in author?s words).
In 1971, the late Dr. Espejel and I informed for the first time the benefits of amantadine in drug-induced dyskinesias (2); consequently, I have f...
Conflict of Interest:
None declared.
Other content recommended for you
- Tardive syndromes
- Movement disorders in psychiatric patients
- Tardive and idiopathic oromandibular dystonia: a clinical comparison
- Spectrum of tardive syndromes: clinical recognition and management
- Prescribed drugs and neurological complications
- Acute dyskinesia in a patient with schizophrenia
- The Bare Essentials
- Emergency presentations of movement disorders
- MIND AND MOVEMENT: THE NEUROPSYCHIATRY OF MOVEMENT DISORDERS
- Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes